Lysophosphatidyl-choline 16:0 mediates persistent joint pain through Acid-Sensing Ion Channel 3: preclinical and clinical evidences

Florian Jacquot(Inserm), Emmanuel Deval(Centre National de la Recherche Scientifique), Éric Lingueglia(Centre National de la Recherche Scientifique), Youssef Aissouni(Inserm), Fabien Marchand(Inserm), Véronique Breuil(Hôpital Pasteur), Lauriane Delay(Inserm), David André Barrière(Université de Tours), Kévin Delanoe(Centre National de la Recherche Scientifique), Aisha Ahmed(Northwestern University), Eva Freyhult(Science for Life Laboratory), Ludivine Pidoux(Centre National de la Recherche Scientifique), Bonnie Labrum(Centre National de la Recherche Scientifique), Alexandra Jurczak(Karolinska Institutet), Spiro Khoury(Université de Poitiers), Camilla I. Svensson(Karolinska Institutet), Kim Kultima(Uppsala University), Eva Kosek(Uppsala University), Thierry Ferreira(Université de Poitiers), A. Katus Hugo, Julie Barbier(Inserm), Agathe Bayle(Inserm)
bioRxiv (Cold Spring Harbor Laboratory)
March 30, 2021
10.1101/2021.03.29.437487
Cited by 3

Related Papers

Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11)
|Pain|2018|3.2k
A classification of chronic pain for ICD-11
|Pain|2015|2.8k
The IASP classification of chronic pain for ICD-11: chronic neuropathic pain
|Pain|2018|1.1k
EULAR evidence-based recommendations for the management of fibromyalgia syndrome
|Annals of the Rheumatic Diseases|2007|751
Brain glial activation in fibromyalgia – A multi-site positron emission tomography investigation
|Brain Behavior and Immunity|2018|304